Geron Corp. Company Profile (NASDAQ:GERN)

About Geron Corp.

Geron Corp. logoGeron Corporation (Geron) is a biopharmaceutical company, which supports the clinical stage development of a telomerase inhibitor, Imetelstat, in hematologic myeloid malignancies by Janssen Biotech, Inc. (Janssen). The Company operates through the segment, which includes discovery and development of therapeutic products for oncology. Imetelstat is a lipid conjugated 13-mer oligonucleotide that is designed to be complementary to and bind with high affinity to the ribonucleic acid (RNA) template of telomerase, thereby directly inhibiting telomerase activity. Imetelstat exhibits relatively preferential inhibition of the clonal proliferation of malignant progenitor cells in nonclinical studies. Janssen is engaged in the development of Imetelstat with over two clinical trials, such as a Phase II trial in myelofibrosis (MF), referred to as IMbark, and a Phase II/III trial in myelodysplastic syndromes (MDS) referred to as IMerge.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: Biotechnology
  • Exchange: NASDAQ
  • Symbol: GERN
  • CUSIP: 37416310
Key Metrics:
  • Previous Close: $2.70
  • 50 Day Moving Average: $2.70
  • 200 Day Moving Average: $2.81
  • Trailing P/E Ratio: 337.50
  • Foreward P/E Ratio: 54.00
  • P/E Growth: -2.35
  • Market Cap: $429.68M
  • Outstanding Shares: 159,139,000
  • Beta: 2.78
Additional Links:
Companies Related to Geron Corp.:

Analyst Ratings

Consensus Ratings for Geron Corp. (NASDAQ:GERN) (?)
Ratings Breakdown: 1 Hold Rating, 4 Buy Ratings
Consensus Rating:Buy (Score: 2.80)
Consensus Price Target: $7.00 (159.26% upside)

Analysts' Ratings History for Geron Corp. (NASDAQ:GERN)
DateFirmActionRatingPrice TargetDetails
8/19/2016BTIG ResearchInitiated CoverageNeutralView Rating Details
5/8/2016FBR & CoReiterated RatingBuyView Rating Details
12/17/2015Janney Montgomery ScottInitiated CoverageBuy$6.50View Rating Details
12/8/2015Piper Jaffray Cos.Reiterated RatingBuyView Rating Details
12/7/2015Oppenheimer Holdings Inc.Reiterated RatingBuy$5.50View Rating Details
8/10/2015MLV & Co.Reiterated RatingBuy$6.00View Rating Details
(Data available from 8/29/2014 forward)


Earnings History for Geron Corp. (NASDAQ:GERN)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/3/2016Q216($0.07)($0.05)$0.38 million$0.21 millionViewListenView Earnings Details
5/5/2016Q116($0.06)($0.06)$0.26 million$0.74 millionViewListenView Earnings Details
2/25/2016Q415($0.05)($0.05)$0.32 million$0.22 millionViewListenView Earnings Details
11/5/2015Q315$0.12$0.17$17.87 million$35.40 millionViewListenView Earnings Details
8/5/2015Q2 15($0.06)($0.05)$0.40 million$0.25 millionViewN/AView Earnings Details
4/30/2015Q1($0.06)($0.06)$0.32 million$0.54 millionViewN/AView Earnings Details
3/3/2015Q4$0.17($0.06)$35.35 million$0.18 millionViewListenView Earnings Details
11/3/2014Q314($0.06)($0.06)ViewN/AView Earnings Details
8/11/2014Q214($0.06)($0.06)$0.22 million$0.34 millionViewListenView Earnings Details
5/1/2014Q114($0.06)($0.06)$0.35 million$0.47 millionViewListenView Earnings Details
3/27/2014($0.06)($0.07)ViewN/AView Earnings Details
3/17/2014Q413($0.07)($0.07)$0.35 millionViewListenView Earnings Details
11/7/2013Q313($0.06)($0.06)$0.49 million$0.18 millionViewListenView Earnings Details
8/8/2013Q2 2013($0.07)($0.07)$0.50 million$0.11 millionViewListenView Earnings Details
4/25/2013Q1 2013($0.08)($0.09)$0.71 million$0.77 millionViewListenView Earnings Details
3/12/2013Q4 2012($0.14)($0.12)$0.50 million$0.69 millionViewListenView Earnings Details
10/30/2012Q312($0.14)($0.13)$0.38 million$0.64 millionViewN/AView Earnings Details
7/31/2012($0.15)($0.14)ViewN/AView Earnings Details
5/2/2012($0.18)($0.15)ViewN/AView Earnings Details
11/3/2011($0.18)($0.16)ViewN/AView Earnings Details
7/28/2011($0.18)($0.17)ViewN/AView Earnings Details
4/27/2011($0.19)($0.20)ViewN/AView Earnings Details
2/24/2011($0.19)($0.39)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Geron Corp. (NASDAQ:GERN)
Current Year EPS Consensus Estimate: $-0.24 EPS
Next Year EPS Consensus Estimate: $0.05 EPS


Dividend History for Geron Corp. (NASDAQ:GERN)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading History for Geron Corp. (NASDAQ:GERN)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/29/2015Olivia Kyusuk BloomCFOSell2,380$3.84$9,139.20View SEC Filing  
3/18/2015Thomas HofstaetterDirectorSell70,000$4.10$287,000.00View SEC Filing  
5/29/2014Melissa Kelly BehrsEVPSell4,826$2.10$10,134.60View SEC Filing  
5/29/2014Olivia Kyusuk BloomCFOSell3,379$2.10$7,095.90View SEC Filing  
5/9/2014Daniel BradburyDirectorBuy142,776$1.75$249,858.00View SEC Filing  
4/1/2014Melissa Kelly BehrsEVPSell12,310$2.13$26,220.30View SEC Filing  
4/1/2014Olivia Kyusuk BloomCFOSell7,435$2.13$15,836.55View SEC Filing  
4/1/2013John A ScarlettCEOBuy50,000$1.03$51,500.00View SEC Filing  
(Data available from 1/1/2013 forward)


Latest Headlines for Geron Corp. (NASDAQ:GERN)
News Icon2 Biotech Stocks News And Price Trends: Geron Corporation ... - The Voice Registrar (NASDAQ:GERN) - August 28 at 9:38 AM logoGERON CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits (NASDAQ:GERN) - August 25 at 5:12 PM
News Icon2 Biotech Stocks News And Price Trends: Geron Corporation (NASDAQ:GERN), ZIOPHARM Oncology, Inc. (NASDAQ ... - The Voice Registrar (NASDAQ:GERN) - August 25 at 10:12 AM logoGeron Corp. breached its 50 day moving average in a Bearish Manner : GERN-US : August 25, 2016 (NASDAQ:GERN) - August 25 at 10:12 AM logoMylan (MYL) Obtains Favorable USPTO Ruling for Copaxone (NASDAQ:GERN) - August 25 at 10:12 AM logoClovis (CLVS) Stock Up on FDA Priority Review for Rucaparib (NASDAQ:GERN) - August 24 at 8:13 AM logoAlder Biopharmaceuticals (ALDR) Jumps: Stock Rises 9.6% (NASDAQ:GERN) - August 23 at 5:21 PM logoGilead (GILD) Truvada Gets EU Approval for Label Expansion (NASDAQ:GERN) - August 23 at 9:35 AM
News IconLet's Take a Closer Look at Geron Corporation (NASDAQ:GERN) - Duncan Research (NASDAQ:GERN) - August 22 at 5:16 PM logoPfizer's (PFE) Pain Drug Troxyca ER Receives FDA Approval (NASDAQ:GERN) - August 22 at 9:50 AM logoCan Geron Corporation (NASDAQ:GERN) Meet Analysts ... - Stocks Daily (NASDAQ:GERN) - August 20 at 5:05 PM logoBTIG Research Initiates Coverage on Geron Corporation (GERN) By Announcing An Initial Rating Of “Neutral” (NASDAQ:GERN) - August 20 at 9:24 AM logoGeron Shares Seen Range-Bound On Lack Of Major Data Until Late 2017 (NASDAQ:GERN) - August 19 at 5:07 PM logoEdited Transcript of GERN earnings conference call or presentation 3-Aug-16 8:30pm GMT (NASDAQ:GERN) - August 18 at 5:13 PM
News IconHot Biotech Stocks Recap: Incyte Corporation (NASDAQ:INCY), Geron Corporation (NASDAQ:GERN) - The Voice Registrar (NASDAQ:GERN) - August 18 at 8:09 AM logoInovio (INO) Veterinary Vaccine Rights Licensed to Plumbline (NASDAQ:GERN) - August 17 at 8:13 AM logoJ&J's (JNJ) Depression Treatment Esketamine Gets BTD (NASDAQ:GERN) - August 17 at 8:13 AM logoETF’s with exposure to Geron Corp. : August 16, 2016 (NASDAQ:GERN) - August 16 at 5:21 PM
News IconSmall Cap Update on: Geron Corporation (NASDAQ:GERN) - Duncan Research (NASDAQ:GERN) - August 15 at 5:22 PM logoGeron Corp. breached its 50 day moving average in a Bullish Manner : GERN-US : August 15, 2016 (NASDAQ:GERN) - August 15 at 11:41 AM
News IconNotable Stock Broker Reports on HP Inc (NYSE:HPQ) (NASDAQ:GERN) - August 11 at 5:25 PM logoGERON CORP Financials (NASDAQ:GERN) - August 11 at 5:25 PM logoIonis (IONS) Q2 Loss Narrower than Expected, Issues Outlook (NASDAQ:GERN) - August 10 at 5:29 PM
News IconHot Biotech Stocks Recap: Geron Corporation (NASDAQ:GERN), Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX) - The Voice Registrar (NASDAQ:GERN) - August 10 at 12:38 PM
News IconZack's analysts upgrade Geron Corp. shares (NASDAQ: GERN) - BNB Daily (blog) (NASDAQ:GERN) - August 8 at 9:56 AM logoDo Geron's Q2 Results Point To A Strong Close In 2016? (NASDAQ:GERN) - August 7 at 4:57 PM logoGeron reports 2Q loss (NASDAQ:GERN) - August 5 at 5:19 PM logoETF’s with exposure to Geron Corp. : August 5, 2016 (NASDAQ:GERN) - August 5 at 5:19 PM logoImmunoGen (IMGN) Reports Wider-than-Expected Loss in Q4 (NASDAQ:GERN) - August 5 at 5:19 PM
News IconMix Cap Most Movers- Geron Corporation (NASDAQ:GERN), Time ... - Seneca Globe (NASDAQ:GERN) - August 5 at 8:05 AM logoGeron Corp. breached its 50 day moving average in a Bullish Manner : GERN-US : August 4, 2016 (NASDAQ:GERN) - August 4 at 5:31 PM logoGeron (GERN) Posts Narrower-Than-Expected Loss in Q2 (NASDAQ:GERN) - August 4 at 5:31 PM logoOverview of Analyst's Recommendations: Advaxis, Inc. (NASDAQ:ADXS) , Geron Corporation (NASDAQ:GERN) - Street Updates (NASDAQ:GERN) - August 4 at 8:04 AM logoAnalyst Rating Update on Geron Corporation (GERN) - Trade Calls (NASDAQ:GERN) - August 4 at 8:04 AM logoEARNINGS SUMMARY: Details of Geron Corporation Q2 Earnings Report (NASDAQ:GERN) - August 3 at 5:29 PM logoGeron Corporation Reports Second Quarter 2016 Financial Results and Recent Events (NASDAQ:GERN) - August 3 at 5:28 PM logoGeron Corp Earnings Call scheduled for 4:30 pm ET today (NASDAQ:GERN) - August 3 at 5:28 PM logoQ2 2016 Geron Corp Earnings Release - After Market Close (NASDAQ:GERN) - August 3 at 8:07 AM logoGeron (GERN) Q2 Earnings: What's in Store for the Stock? (NASDAQ:GERN) - August 1 at 8:38 AM
News IconActive biotech company shares in the news: Geron Corporation (NASDAQ:GERN), ImmunoCellular Therapeutics, Ltd ... - The Voice Registrar (NASDAQ:GERN) - July 30 at 8:04 AM logoGeron Announces Conference Call to Discuss Second Quarter 2016 Financial Results (NASDAQ:GERN) - July 27 at 8:08 AM logoGERON CORP Files SEC form 8-K, Other Events (NASDAQ:GERN) - July 25 at 8:02 AM
News IconTrading the Biotech News: Geron Corporation (NASDAQ:GERN), Medivation, Inc. (NASDAQ:MDVN) - The Voice Registrar (NASDAQ:GERN) - July 24 at 4:55 PM logoETF’s with exposure to Geron Corp. : July 20, 2016 (NASDAQ:GERN) - July 20 at 12:29 PM
News IconGeron Corporation (NASDAQ:GERN) Earnings Concentration and Analyst Target Watch - Engelwood Daily (NASDAQ:GERN) - July 20 at 8:04 AM logoAnalysts Rating Overview: Bristol-Myers Squibb Company (NYSE:BMY) , Geron Corporation (NASDAQ:GERN) - Street Updates (NASDAQ:GERN) - July 19 at 5:19 PM logoShares of Geron Corporation (GERN) Drops by -2.21% - Trade Calls (NASDAQ:GERN) - July 19 at 5:19 PM logoGeron Corporation (GERN): Price Target and June Short Interest Disclosure - Trade Calls (NASDAQ:GERN) - July 15 at 8:10 AM logoGeron awarded three patents for telomerase inhibitor (NASDAQ:GERN) - July 14 at 5:21 PM logoGeron Corp (GERN) Receives Three U.S. Patents Related to Imetelstat (NASDAQ:GERN) - July 14 at 5:21 PM


Geron Corp. (NASDAQ:GERN) Chart for Monday, August, 29, 2016

Last Updated on 8/29/2016 by Staff